| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 07/05/2006 | EP1675845A2 Glutamine fructose-6-phosphate amidotransferase (gfat) inhibitors |
| 07/05/2006 | CN1798737A Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines |
| 07/05/2006 | CN1798723A Method for the treatment or prevention of lower urinary tract symptoms |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | CA2130797C 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity, and synthesis of .alpha.-substituted-arylacetamides |
| 06/29/2006 | WO2006067587A2 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/29/2006 | WO2006067444A1 Amide derivatives |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | CA2592092A1 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/29/2006 | CA2589764A1 Amide derivatives |
| 06/27/2006 | US7067553 Thiourea compounds and the pharmaceutical compositions containing the same |
| 06/27/2006 | US7067533 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067529 a 1-benzoyl-6- or 7-methoxy-isoquinoline; antidiabetic agents; Type II diabetes |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/22/2006 | WO2006066197A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | WO2006064075A1 Isoquinoline derivatives as calpain inhibitors |
| 06/22/2006 | WO2006052555A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/22/2006 | US20060135557 neurodegenerative diseases such as Alzheimer's disease, apoplexy and brain ischemic injuries |
| 06/22/2006 | CA2592353A1 Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 06/22/2006 | CA2588389A1 Substituted phenols as active agents inhibiting vegf production |
| 06/21/2006 | EP1671649A1 Remedy for diabetes |
| 06/21/2006 | EP1670766A1 Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases |
| 06/21/2006 | EP1670458A1 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics |
| 06/21/2006 | CN1791581A Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 06/21/2006 | CN1791407A [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/20/2006 | US7064211 Hemiasterlin derivatives and uses thereof |
| 06/20/2006 | US7063903 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006063294A2 Novel inhibitors of histone deacetylase for the treatment of disease |
| 06/15/2006 | WO2006061217A2 Saquinavir derivatives useful in immunoassay |
| 06/15/2006 | WO2006023778A3 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | CA2590141A1 Saquinavir derivatives useful in immunoassay |
| 06/14/2006 | EP1667989A1 Substituted isoquinolinones |
| 06/14/2006 | EP1667982A2 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667981A1 Isoquinoline potassium channel inhibitors |
| 06/14/2006 | EP1667980A1 1,4-disubstituted isoquinoline derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 06/14/2006 | EP1667979A2 Isoquinoline potassium channel inhibitors |
| 06/14/2006 | EP1667978A2 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667977A1 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667976A1 Isoquinolinone potassium channel inhibitors |
| 06/14/2006 | EP1667675A1 Entry inhibitors of the hiv virus |
| 06/14/2006 | CN1785978A Tetra hydro iso quinoline compounds possessing anti breed and anti fungus activity and its salt |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060832 Nitrogen-containing fused heterocyclic carboxylic acids having an absolute configuration of “R” |
| 06/13/2006 | US7060707 Isoquinoline derivatives |
| 06/13/2006 | CA2387997C Process for preparing oxazolines from tetrahydrofurans |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006026533A3 Methods of treatment of amyloidosis using ethanol cyclicamine derivatives aspartyl protease inhibitors |
| 06/08/2006 | WO2005120505A3 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 06/08/2006 | US20060122388 Thiocarbamate inhibitors of alpha-4 integrins |
| 06/07/2006 | EP1664088A2 Hemiasterlin derivatives and uses thereof |
| 06/07/2006 | EP1664023A1 Sustituted isoquinoline derivatives and methods of use |
| 06/07/2006 | EP1663983A1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 06/07/2006 | EP1663234A1 Piperazine derivatives for the treatment of hiv infections |
| 06/07/2006 | EP1373188B1 Alanine 2,6-dialkoxyphenyl ester derivatives as hypnotics |
| 06/07/2006 | EP1311478B1 Novel (thio)urea compounds and the pharmaceutical compositions containing the same |
| 06/07/2006 | CN1784382A 7-amino- isoindolyl compounds amd their pharmaceutical uses |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 06/06/2006 | CA2136903C Acetic acid derivatives |
| 06/01/2006 | WO2006014918A3 Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 06/01/2006 | US20060116326 Benzothiophene compounds having antiinfective activity |
| 06/01/2006 | CA2588773A1 4-phenyl substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| 05/31/2006 | EP1661881A2 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 05/31/2006 | EP1660471A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 05/31/2006 | EP1660455A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/31/2006 | EP1660454A1 Azacyclic compounds as inhibitors of sensory neurone specific channels |
| 05/31/2006 | EP1660443A2 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
| 05/31/2006 | EP1660137A2 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors |
| 05/31/2006 | EP1420644B1 Substituted propargylamines |
| 05/31/2006 | EP1401821A4 Novel phenylalkyl diamine and amide analogs |
| 05/31/2006 | CN1257896C Functional molecule material containing four tertiary amine branches and preparation method |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053211 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 05/30/2006 | US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 05/30/2006 | US7053093 Nitrogen compounds such as 1-((3- Phenylimidazo(5,1-a)-isoquinolin-6-yl)carbonyl)piperidine, that bind preferentially to gamma-aminobutyric acid (GABAA) receptors; prophylaxis of nervous system disorders |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/26/2006 | WO2005108358A3 Pyrrolidine derivatives useful as bace inhibitors |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/24/2006 | EP1659112A1 Arylpiperazuine derivatives as selective ligand for the dopamine D3 receptor |
| 05/24/2006 | EP1658269A1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/24/2006 | EP1658264A2 Methods and compositions for treating amyloid-related diseases |
| 05/24/2006 | DE10347386B4 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 05/24/2006 | CN1777577A Antibacterial agents |
| 05/23/2006 | US7049442 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins |
| 05/23/2006 | US7049330 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 05/18/2006 | WO2006052430A2 Opiate intermediates and methods of synthesis |
| 05/18/2006 | WO2006051704A1 Imine compound |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060104907 Biologically potent analogues of the Dmt-Tic pharmacophore and methods of use |
| 05/18/2006 | CA2587667A1 Imine compound |
| 05/18/2006 | CA2586156A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 05/18/2006 | CA2585698A1 Opiate intermediates and methods of synthesis |